Stock Analysts’ Updated EPS Estimates for August, 8th (ADUS, ALRM, CEVA, CYBR, HEI, IOTS, MNK, ONCE, ORLY, QURE)

Stock Analysts’ updated eps estimates for Wednesday, August 8th:

Addus Homecare (NASDAQ:ADUS) had its price target raised by Oppenheimer Holdings Inc. from $50.00 to $72.00. They currently have an outperform rating on the stock.

AlarmCom (NASDAQ:ALRM) had its target price boosted by Roth Capital from $51.00 to $57.00. Roth Capital currently has a buy rating on the stock.

CEVA (NASDAQ:CEVA) had its price target reduced by Roth Capital from $44.00 to $35.00. Roth Capital currently has a buy rating on the stock.

Cyberark Software (NASDAQ:CYBR) had its price target boosted by Oppenheimer Holdings Inc. from $65.00 to $75.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.

Robert W. Baird assumed coverage on shares of Heico (NYSE:HEI). They issued a neutral rating on the stock.

Adesto Technologies (NASDAQ:IOTS) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $12.00 price target on the stock. The analysts wrote, “We are adjusting our 4Q18 estimates and 2019 estimates to include the associated OPEX related to Echelon and the potential $6-$8 cost savings, which we assume occurs in the OPEX line. For 4Q18, we increase our OPEX by $4.4MM to $13.1MM to reflect a full quarter of operations of Echelon. For 2019, our OPEX increases to $47.8MM from $31.9MM to reflect a full year of of savings. Our $12 PT remains 2.4x EV/sales (2019).””

Mallinckrodt (NYSE:MNK) had its price target increased by Leerink Swann from $12.00 to $27.00. The firm currently has a market perform rating on the stock.

Spark Therapeutics (NASDAQ:ONCE) had its target price trimmed by SunTrust Banks, Inc. to $61.00. They currently have a buy rating on the stock.

O’Reilly Automotive (NASDAQ:ORLY) had its price target raised by Oppenheimer Holdings Inc. from $305.00 to $360.00. The firm currently has an outperform rating on the stock.

Uniqure (NASDAQ:QURE) had its buy rating reaffirmed by analysts at Janney Montgomery Scott.

Strongbridge Biopharma (NASDAQ:SBBP) had its price target boosted by Janney Montgomery Scott to $16.00. Janney Montgomery Scott currently has a buy rating on the stock.

Tabula Rasa HealthCare (NASDAQ:TRHC) had its target price boosted by Piper Jaffray Companies to $71.00. They currently have an overweight rating on the stock.

Verso (NYSE:VRS) had its target price raised by BWS Financial from $32.00 to $40.00. They currently have a strong-buy rating on the stock.

Receive News & Ratings for Addus Homecare Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare Co and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply